Clinical trial Recruiting at 1 site Interventional Ages 45 to 85

Effects of tactile cueing on walking in Parkinson's disease

Official title: Cortical Correlates of Gait in Parkinson's Disease: Impact of Medication and Cueing

Run by Oregon Health and Science University · NCT05818189 · Data updated 2026-11-12

This study is testing whether a special system that gives touch cues can help people with Parkinson's disease walk better and more smoothly.

More Parkinson Disease trials

Quick facts

Study typeInterventional
Ages45 Years to 85 Years
SexAll
Enrollment60 (estimated)
SponsorOregon Health and Science University
Academic / other
Locations1 site (Portland, Oregon)
StatusRecruiting
StartedJanuary 15, 2025
Main results expectedOctober 1, 2027
Study endsJanuary 31, 2028
Registry record updatedDecember 17, 2025
Trial IDNCT05818189 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are individuals diagnosed with idiopathic Parkinson's disease who exhibit bradykinesia and are capable of following study protocols.

Probably not a fit

Patients with severe dyskinesia or other significant neurological or musculoskeletal disorders may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study investigates how a personalized tactile cueing system affects gait automaticity in individuals with Parkinson's disease. Participants will be randomized into two groups: one receiving step-synchronized tactile cues and the other receiving fixed interval cues as a control. The researchers aim to measure changes in gait variability and speed, as well as cortical activity using functional near-infrared spectroscopy (fNIRS). The goal is to understand the relationship between cueing, gait performance, and brain activity, potentially leading to improved walking strategies for patients.

Why it matters

Potential benefit: If successful, this study could enhance walking ability and quality of life for patients with Parkinson's disease by improving gait automaticity.

How similar studies have gone: While the approach of using tactile cueing is innovative, similar studies have shown promise in improving gait in Parkinson's disease, suggesting potential for success.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Diagnosis of idiopathic Parkinson's Disease from movement disorders neurologist with the United Kingdom Brain Bank criteria of bradykinesia with 1 or more of the following - rest tremor, rigidity, and balance problems not from visual, vestibular, cerebellar or proprioceptive conditions
* Without musculoskeletal or peripheral or central nervous system disorders (other than PD) that could significantly affect their balance and gait
* All subjects will be capable of following directions for the protocols and to give informed consent.
* Hoehn \& Yahr Levels II-III.

Exclusion Criteria:

* Severe dyskinesia that may affect quality of fNIRS.
* Major musculoskeletal or neurological disorders, structural brain disease, epilepsy, acute illness or health history, other than Parkinson's Disease, significantly affecting gait and turning i.e., peripheral neuropathy with proprioceptive deficits (detected as lack of toe proprioception assessed during the neurological exam at Day 1), musculoskeletal disorders, vestibular problem, head injury, stroke.
* Montreal cognitive assessment (MoCA) score \< 21 or dementia that precludes consent to participate or ability to follow testing procedures
* Inability to stand or walk for 2 minutes without an assistive device.
* Idiopathic Parkinson's Disease exclusion criteria: Parkinson plus syndromes such as progressive supranuclear palsy, multiple system atrophy, or corticobasal syndrome or implanted electrodes for deep brain stimulation (DBS), possible vascular parkinsonism, current use of dopamine-blocking agents or cholinesterase inhibitor (as may affect Prefrontal cortical activity while walking).

Where it's running

  • Oregon Health and Science University
    Portland, Oregon, United States
    Recruiting

Study contacts

  • Principal investigator: Martina Mancini, PhD — Oregon Health and Science University
  • Study coordinator: Francesa Alcalá, B.S.
  • Email: alcalaf@ohsu.edu
  • Phone: 503-913-3691

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.